News in brief: Key Neurotech phase III trial underway; London dates confirmed for Cannabis Europa; Vitura sets AGM date by Steve Jones September 22, 2026September 24, 2026 Drug development firm Neurotech International (NTI) has dosed the first patient in its pivotal phase III […]
Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026
Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026
